Diversified Healthcare Trust (DHC) 주식 분석

회사 개요

Diversified Healthcare Trust (DHC) is a real estate investment trust dedicated to acquiring and managing high-quality healthcare properties situated across the United States. The company operates within the Real Estate sector, specifically classified under the REIT - Healthcare Facilities industry, which implies a focus on income generation through rental agreements rather than trading stocks. With a market capitalization of $1.77B and annual revenue of $1.54B, DHC represents a significant entity in the specialized real estate market. While the specific employee count is not disclosed, the scale indicated by the $1.77B market cap suggests substantial asset holdings and operational reach. The revenue figure of $1.54B annually reflects the aggregate value derived from its portfolio of healthcare facilities, positioning the company as a major player in the healthcare real estate landscape. This valuation indicates that the trust manages a vast portfolio capable of generating billions in gross revenue, underscoring its established footprint in the US healthcare infrastructure.

재무 건전성

The company reported revenue of $1.54B over the trailing twelve months, yet recorded a net income of -$285.89M, revealing a substantial gap between top-line performance and bottom-line profitability. This significant divergence highlights a cost structure where operating expenses, interest payments, or other deductions far exceed the earnings before interest and taxes. Despite the net loss, the entity generated an EBITDA of $222.77M, indicating that operational cash generation remains positive before financing costs. Furthermore, the free cash flow stands at $445.83M, which provides the company with considerable financial flexibility to service debt or fund maintenance without relying on external capital markets. The gross margin is recorded at 17.4%, while the operating margin is negative at -2.9%, and the profit margin is significantly depressed at -18.6%. These margin figures collectively indicate that while the core property operations are reasonably efficient at generating gross profit, high overhead costs or interest burdens are eroding operating and net profits. In terms of liquidity, the company holds $105.41M in cash against total debt of $2.42B, resulting in a debt-to-equity ratio of 145.16. This balance sheet configuration suggests a highly leveraged position where debt obligations significantly outweigh equity capital. The current ratio is 6.08, which indicates a robust ability to meet short-term obligations with its liquid assets. Finally, the return on equity is -15.8% and the return on assets is -0.5%, metrics that reveal that management has not yet been effective in generating positive returns on the shareholders' capital or the total asset base.

밸류에이션 평가

The trailing P/E ratio is not applicable due to negative earnings, whereas the forward P/E is listed as -16.95, implying that analysts do not expect earnings to become positive in the near term. The price-to-book ratio is 1.06, suggesting that the market values the company's equity at only 6% above its book value. The price-to-sales ratio is 1.15, and the EV/EBITDA stands at 18.30, indicating that the stock trades at a premium relative to its sales but with a valuation multiple that reflects its negative earnings trajectory. The 52-week high is $7.66 and the 52-week low is $2.00, providing a clear range of price volatility observed over the last year. Without the current price explicitly stated in the provided facts, the relative trading position cannot be calculated; however, the wide range between the high and low demonstrates significant price instability. The beta value is 2.33, which indicates that the stock's price volatility is more than twice that of the broader market. This high beta suggests that DHC is highly sensitive to market fluctuations and experiences amplified price movements compared to less volatile assets.

Growth & Income

Revenue growth year-over-year is 0.0%, and earnings growth year-over-year is not applicable, indicating a stagnation in top-line expansion and a lack of measurable earnings progression. Since the earnings growth is not applicable and revenue growth is flat, the company is not currently growing its earnings faster than its revenue, as both metrics show no positive expansion. Regarding income, the dividend yield is 0.6% with a payout ratio of 2.3%. Given the negative net income of -$285.89M, the payout ratio is technically not sustainable from an earnings perspective, as dividends are likely being funded from cash flows or reserves rather than current profits. The overall growth and income profile is characterized by a lack of revenue expansion, flat earnings, and a minimal dividend yield that does not reflect strong profitability. The financial data presents a picture of a mature, leveraged asset that generates significant cash flow but struggles to translate that into net income or revenue growth.